Zostavax Is Brand Name For Merck’s Herpes Zoster Vaccine
This article was originally published in The Pink Sheet Daily
Merck has chosen Zostavax as the brand name for its Phase III herpes zoster vaccine
You may also be interested in...
Gardasil's marketing model will be closer to a blockbuster pharmaceutical than to a traditional vaccine, CEO Gilmartin says. The company sees a parallel to the roll-out of Fosamax for osteoporosis.
Surge of interest prompts US FDA to consider how to adjust feedback, including potentially creating a separate team to answer more basic questions.
When the closest you can get to US FDA staff is Webex, the meeting minutes and interactions with the review team project manager take on increased importance, consultants suggest during an Informa-sponsored webinar.